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FDA safety communications related to highly prescribed prod-
ucts including the thiazolidinediones and bisphosphonates in
2007, information on drug safety was present weekly, if not
daily, in the newspaper and on television. To assist consumers in
understanding their risk of developing serious side effects and put
into context the relative risk of their various medications, we
have developed a 5-color drug risk rating system. METHODS:
The iGuard Risk Rating system is a patented process for sum-
marizing serious adverse events contained in each medication’s
Prescribing Information. Speciﬁcally, we focus on: 1) the severity
of the reaction (serious disability or death); 2) the likelihood of
the reaction (e.g., >1 in 10,000); and 3) proportion of the popu-
lation affected (e.g., 0–15%). We also adjust for lack of experi-
ence with a product on the market: <1,000,000 prescriptions or
<2 years post-launch. Our iGuard Risk Ratings, from lowest to
highest, are as follows: 1) Green: Low Risk–Suitable for wide-
spread use; 2) Blue: General Risk–Use under normal care of a
doctor; 3) Yellow: Guarded–Be on the lookout for safety events;
4) Orange: Elevated Risk–Create a personal risk reduction plan
with your doctor; and 5) Red: High Risk–Requires careful con-
sideration of risk versus beneﬁt. RESULTS: To date, we have
rated 106 medications. Risk Ratings associated with individual
medications are available on the project website at www.i-
guard.org. A total of 80 of 106 medications (75%) were rated
Level 2/Blue: General Risk. An additional 20% were rated Level
4/Orange: Elevated Risk. Ratings across molecules within a
therapeutic class are very similar. CONCLUSION: Consumer
feedback on the iGuard Risk Ratings has been very positive,
especially in understanding which of their medications they need
to be most diligent in monitoring.
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OBJECTIVE: Ethnic disparities in hospital discharges against
medical advice (AMA) have been examined in previous studies.
However, the institutional factors affecting health decision
making have received much less attention. This study examines
the evidence for a joint impact of ethnicity and hospital quality
on the likelihood of a discharge AMA in patients with cardio-
vascular disease (CVD). METHODS: Adult patients hospitalized
with a primary admissions diagnosis of CVD from 2000 to 2005
were identiﬁed in a state-wide conﬁdential inpatient hospital
discharge dataset. The dataset was augmented with information
from several sources, including the Joint Commission on
Accreditation of Healthcare Organizations (JCAHO). A high
quality hospital was deﬁned as a hospital whose performance
exceeded the state average on each JCAHO hospital performance
measure. A hierarchical generalized linear logistic model of a
discharge against medical advice controlling for various indi-
vidual and contextual factors was estimated using cross-sectional
data. RESULTS: A total of 2593 of the 328,342 hospitalizations
for CVD (0.8%) resulted in a discharge AMA. The patients
self-identiﬁed as non-caucasian in thirty percent (N = 100,074)
of the hospitalizations. Fifteen percent (N = 48,177) of the hos-
pitalizations occurred in high quality hospitals. The adjusted
odds of a discharge AMA in a low quality hospital were lower for
non-Caucasians (OR = 0.74; p = 0.0005) compared to Cauca-
sians while the adjusted odds of a discharge AMA in a high
quality hospital were unchanged between Caucasians and
non-Caucasians (OR = 0.95; p = 0.6). Among Caucasians, a dis-
charge AMA was less likely (OR = 0.75; p = 0.01) at a high
quality hospital compared to a low quality hospital while, among
non-Caucasians, the odds of a discharge AMA were unchanged
(OR = 0.96; p = 0.74) across hospital quality groups. CONCLU-
SION: The two unique and complementary ﬁndings here are
that: 1) institutional quality mediates the relationship between
ethnicity and hospital discharges AMA; and 2) the relationship
between hospital quality and discharges AMA varies with
ethnicity.
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OBJECTIVE: Spending on direct-to-consumer advertising
(DTCA) has seen exponential growth since the late 1990s. The
purpose of this research was to assess the association between
DTCA spending and drug utilization and reimbursement in
the U.S. Medicaid market. METHODS: National direct-to-
consumer advertising expenditures were obtained from Advertis-
ing Age for selected brands in three drug classes: HMG Co-A
reductase inhibiting agents (statins), anti-ulcer/GERD medica-
tions, and antidepressants. The drug utilization and reimburse-
ment (sales) data were extracted from the national Medicaid
pharmacy ﬁles provided by the Centers for Medicare & Medicaid
Services. The annual advertising expenditures, drug utilization,
and reimbursement were charted from 2000 to 2005. Correla-
tion analysis was used to assess the association between both
contemporaneous and lagged DTCA spending by pharmaceutical
companies and drug utilization and reimbursement for each of
the three therapeutic classes. RESULTS: A wide range of esti-
mated Pearson correlation coefﬁcients were derived, including
some negative coefﬁcients. The strongest positive correlations
were found for the statins and antidepressants for the year 2003.
Only antidepressants had a statistically signiﬁcant correlation
(r = 0.58, p < 0.05) between DTCA and reimbursement/
utilization based on a pooled correlation analysis from 2000 to
2005. CONCLUSION: Utilization rates and reimbursement in
the Medicaid market for the investigated medications were not
consistently statistically impacted by DTCA. While there is evi-
dence of a strong correlation for antidepressants, there is less
compelling evidence for statins, and none for the anti-ulcer
drugs. Although both utilization and expenditures in Medicaid
were growing for all three classes, their growth was due to
factors beyond DTCA.
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OBJECTIVE: To describe the amount and types of unused con-
trolled substances (CS) at the time of death in home hospice and
to describe methods used by hospice nurses to destroy CS after
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